The global Urinalysis market is segmented on the basis of product, application, end user, and region. Market growth is largely driven by factors such as the growing global prevalence of kidney diseases and urinary tract infections, the shift towards automation in sediment analysis, and the increasing adoption of point-of-care urinalysis.
On the basis of test type, the urinalysis
market is segmented into biochemical urinalysis, sediment urinalysis, and
pregnancy & fertility tests. In 2019, pregnancy & fertility tests are
expected to account for the largest market share. Growing use of these kits in
home care settings is driving the growth of this segment.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294
Based on application, the urinalysis market
is segmented into disease screening and pregnancy and fertility. In 2019, the
disease screening segment accounted for the largest market share owing to the
fact that urine analysis has become a part of the general check-up in hospitals
and clinics. Pregnancy and fertility testing is carried out using the kits
available in the market either in home care settings or in clinics.
By end user, the urinalysis market is segmented into hospitals & clinics,
diagnostic laboratories, home care settings, and research laboratories &
institutes. In 2019, hospitals & clinics are expected to account for the
largest share of 40% of the market. The large share of this segment can be
attributed to factors such as the rapidly growing aging population, the
increase in reimbursements for clinical tests performed in hospitals, and the
launch of automated urinalysis devices.
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294
On the basis of region, the urinalysis market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America commanded the largest share of the urinalysis market. The large share of this market segment can be attributed to the increasing incidence of chronic kidney diseases and UTIs as well as the increasing adoption of technologically advanced automated devices in the region.
The major players operating in this market are Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc. (Japan), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), Biorad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China).
Read More@
https://www.marketsandmarkets.com/PressReleases/urinalysis-systems.asp
